The Camphor Market is estimated to be valued at USD 573.7 million in 2025 and is projected to reach USD 874.0 million by 2035, registering a compound annual growth rate (CAGR) of 4.3% over the forecast period.
| Metric | Value |
|---|---|
| Camphor Market Estimated Value in (2025 E) | USD 573.7 million |
| Camphor Market Forecast Value in (2035 F) | USD 874.0 million |
| Forecast CAGR (2025 to 2035) | 4.3% |
The camphor market is experiencing steady growth driven by its widespread use in pharmaceutical, personal care, and aromatherapy applications. Demand is being supported by the increasing adoption of camphor for its therapeutic and medicinal properties, particularly in respiratory treatments, analgesics, and topical formulations. Growing awareness of natural and herbal remedies is enhancing its preference over synthetic alternatives in multiple regions.
The market is also being influenced by the expansion of pharmaceutical manufacturing facilities and rising investments in traditional medicine and wellness sectors. Regulatory frameworks favoring natural ingredients and quality control measures are further supporting market adoption. Camphor’s multifunctional properties, including antimicrobial, anti-inflammatory, and aromatic characteristics, are broadening its application spectrum.
As consumers and healthcare providers continue to seek natural compounds with proven efficacy, the camphor market is expected to maintain steady growth Innovations in delivery forms, such as tablets and oils, and improvements in production and standardization processes are also paving the way for sustained market expansion globally.
The camphor market is segmented by form, end-use industry, and geographic regions. By form, camphor market is divided into Tablets, Oil, and Powder. In terms of end-use industry, camphor market is classified into Pharmaceuticals, Agriculture, Food & Beverage, Chemicals, and Others. Regionally, the camphor industry is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.
The tablets form segment is projected to hold 48.2% of the camphor market revenue share in 2025, making it the leading form. This dominance is being driven by the convenience and dosage precision that tablets offer for pharmaceutical and therapeutic use. Tablets allow for controlled release, stability, and ease of administration, which are key factors in patient compliance and acceptance.
The widespread availability of camphor in tablet form enables easy integration into established pharmaceutical supply chains and retail channels. Additionally, tablets can be standardized for quality and potency, ensuring consistent efficacy across different batches. This form is particularly suitable for respiratory and topical applications where accurate dosing is required.
The preference for tablets is being reinforced by their long shelf life and compatibility with modern manufacturing and packaging processes Consequently, the segment continues to dominate due to its accessibility, reliability, and cost-effectiveness for both producers and end-users, positioning it as the most favored form in the camphor market.
The pharmaceuticals end-use industry segment is expected to hold 23.6% of the camphor market revenue share in 2025, establishing it as the leading application sector. Its growth is being driven by the widespread use of camphor in medicinal formulations for respiratory ailments, analgesic preparations, and dermatological treatments. The segment is further supported by increasing healthcare infrastructure investments, rising consumer awareness of herbal remedies, and the integration of camphor into standardized pharmaceutical products.
Regulatory emphasis on natural ingredients and quality control standards ensures that camphor-based pharmaceutical formulations meet stringent efficacy and safety requirements. Its multifunctional properties, including antimicrobial, anti-inflammatory, and soothing effects, make it a versatile active ingredient in a variety of over-the-counter and prescription medications.
The segment’s growth is also being reinforced by the rising trend of combining traditional herbal compounds with modern pharmaceutical formulations to improve therapeutic outcomes As demand for natural medicinal solutions continues to rise, the pharmaceutical sector is expected to remain the largest end-user of camphor, maintaining a strong market share.
While the world is making a shift away from the use of chemicals in various products that are used on a daily basis, camphor is emerging as a popular chemical ingredient in most of the natural end products.
Being a translucent terpene ketone, white/grey in colour, and crystalline in form, camphor does not only have a pleasant odour, but it also offers versatile physical properties - which usually depend on its species, origin, and other specific growing conditions.
Though camphor is commonly produced by the distillation of bark and wood of the camphor tree, it can also be manufactured synthetically; carrying out the synthesis of turpentine oil which is produced from rosin, kinleith, and pine wood among multiple other ingredients.
Camphor is most commonly used in various healthcare products mainly due to its medicinal properties, and these products can be used as a treatment for cough, congestion, and other skin-related infections. Camphor is also used as an insecticide in food storages - a most commonly used traditional insecticide, especially in some countries across South Asia.
Furthermore, camphor oil is also one of the popular remedies for improving digestion, metabolism, and excretion processes. Being an FDA-approved chemical, camphor is gaining immense demand in most of the medicinal, healthcare products, which is predominantly driving growth of the camphor market.
The global market for camphor is highly characterised with its association with a wide range of end-use industries. However, the pharmaceuticals industry is expected to account for a significant share in the increasing global demand for camphor. Especially in cough-related remedial products, such as vapour rub and ointments, camphor has witnessed complete acceptance from the healthcare and pharmaceuticals industry.
Furthermore, the pharmaceuticals industry is also accepting camphor oil as an integral ingredient in natural skincare products, as camphor oil can be positively used in the treatment of various skin-related infections. Its use in muscle relaxant ointments is also opening a new window of opportunities for stakeholders in the camphor market.
In the coming years, leading players are likely to focus on expanding the target audience in a vast range of industries, and capitalize on the growing acceptance for camphor in most of the pharmaceutical and healthcare industries across the world.
Though the global outbreak of the novel coronavirus has instigated a global lockdown, camphor market may continue to witness high demand in the coming years.
Growing awareness about the medical properties of camphor that treat cough-related infections is triggering the use of camphor oil and tablets as a traditional and natural remedy to prevent the coronavirus infection. However, as most of the industrial activities have slowed down, this may be a negative impact on the production of pharma-grade camphor, and this may influence the growth dynamics of the global camphor market in the coming years.
The global market for camphor is divided into seven geographical segments - North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa. The Asia Pacific region is expected to account for a significant revenue share in the global camphor market, mainly accounting for the use of camphor in a variety of traditional medicinal products.
As camphor is among the most commonly used household goods, leading manufacturers are aiming to maintain a healthy demand-supply balance in the Asia Pacific region, in the coming years.
North America is also emerging as a profitable regional market for camphor manufacturers, distributors, and other stakeholders. A mounting number of end-use industries are moving to replacing chemicals with camphor to avail its natural, medicinal properties, in order to sync with the consumer demand for ‘all natural’ products.
As a result, leading players in the global camphor market will witness a burgeoning demand from the end-use industries situated in the North American region, in the foreseeable future.
The global camphor market witnesses intense competition, while leading players are aiming to gain a competitive edge by introducing a price differentiation. This makes it a price sensitive market, leaving very little or no scope for market players to introduce product differentiation.
Furthermore, being highly fragmented in nature, the global market for camphor market is likely to witness a significant stronghold of regional manufacturers, as they leverage on the benefits of low capital investments.
Leading players are likely to introduce their own end products using camphor to stay ahead of the curve, and this will emerge as a prominent strategy of growth among a majority of market players in the coming years.
Palm Organix Company (Palm Organix™) - a New York-based leading player in the vitamins & supplements industry - announced in September 2025, that it will be introducing its new line of skincare products - ‘Zero THC CBD Lotion w/ Camphor’.
The line includes products with Phytocannabinoid-Rich Hemp Oil with Camphor and other essential oils, such as camphor oil, to create a light fresh CBD lotion.
In June 2025, Mother Sparsh - an Indian manufacturer of plant-based, natural and eco-friendly baby care products - announced that it has launched a natural insect repellent product which is made of camphor oil and other pure natural ingredients such as eucalyptus oil, lemongrass oil, and citronella oil.
These incidences of skincare products being launched by market players further amplifies the profitability of camphor oil in various end-use industries.
| Country | CAGR |
|---|---|
| China | 5.8% |
| India | 5.4% |
| Germany | 4.9% |
| France | 4.5% |
| UK | 4.1% |
| USA | 3.7% |
| Brazil | 3.2% |
The Camphor Market is expected to register a CAGR of 4.3% during the forecast period, exhibiting varied country level momentum. China leads with the highest CAGR of 5.8%, followed by India at 5.4%. Developed markets such as Germany, France, and the UK continue to expand steadily, while the USA is likely to grow at consistent rates. Brazil posts the lowest CAGR at 3.2%, yet still underscores a broadly positive trajectory for the global Camphor Market. In 2024, Germany held a dominant revenue in the Western Europe market and is expected to grow with a CAGR of 4.9%. The USA Camphor Market is estimated to be valued at USD 212.8 million in 2025 and is anticipated to reach a valuation of USD 304.7 million by 2035. Sales are projected to rise at a CAGR of 3.7% over the forecast period between 2025 and 2035. While Japan and South Korea markets are estimated to be valued at USD 30.3 million and USD 19.6 million respectively in 2025.
| Item | Value |
|---|---|
| Quantitative Units | USD 573.7 Million |
| Form | Tablets, Oil, and Powder |
| End-Use Industry | Pharmaceuticals, Agriculture, Food & Beverage, Chemicals, and Others |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, Middle East & Africa |
| Country Covered | United States, Canada, Germany, France, United Kingdom, China, Japan, India, Brazil, South Africa |
| Key Companies Profiled | Beijing Herbal Health Biotech LLC, Taiwan Tekho Camphor Co., Ltd, Indukern Internacional, Saptagir Camphor Ltd., Camphor and Allied Products ltd., and Hunan Nutramax Inc. |
| Additional Attributes |
The global camphor market is estimated to be valued at USD 573.7 million in 2025.
The market size for the camphor market is projected to reach USD 874.0 million by 2035.
The camphor market is expected to grow at a 4.3% CAGR between 2025 and 2035.
The key product types in camphor market are tablets, oil and powder.
In terms of end-use industry, pharmaceuticals segment to command 23.6% share in the camphor market in 2025.
Explore Similar Insights
Camphor Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
